Project Details
Description
A Novel Melanoma Vaccine Based on a Shared Neoantigen and a Liquid Polymer Platform
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/23 → 2/28/25 |
Funding
- TREKKA THERAPEUTICS, LLC
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.